| Title |
Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia
|
|---|---|
| Published in |
Stem Cell Research & Therapy, May 2020
|
| DOI | 10.1186/s13287-020-01725-4 |
| Pubmed ID | |
| Authors |
Yingxin Zhang, Jie Ding, Shaoda Ren, Weihua Wang, Yapei Yang, Shuangjing Li, Min Meng, Tiejun Wu, Daliang Liu, Suochen Tian, Hui Tian, Shuangfeng Chen, Changhui Zhou |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | 25% |
| United Kingdom | 1 | 25% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 50% |
| Scientists | 1 | 25% |
| Science communicators (journalists, bloggers, editors) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 226 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 226 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 29 | 13% |
| Student > Bachelor | 29 | 13% |
| Researcher | 22 | 10% |
| Student > Ph. D. Student | 18 | 8% |
| Other | 14 | 6% |
| Other | 41 | 18% |
| Unknown | 73 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 60 | 27% |
| Biochemistry, Genetics and Molecular Biology | 23 | 10% |
| Nursing and Health Professions | 17 | 8% |
| Agricultural and Biological Sciences | 12 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
| Other | 32 | 14% |
| Unknown | 76 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 January 2024.
All research outputs
#1,717,986
of 25,263,619 outputs
Outputs from Stem Cell Research & Therapy
#84
of 2,738 outputs
Outputs of similar age
#45,398
of 401,484 outputs
Outputs of similar age from Stem Cell Research & Therapy
#4
of 72 outputs
Altmetric has tracked 25,263,619 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,738 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 401,484 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 72 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.